Norflex and Gait abnormalities - a phase IV clinical study of FDA data
We study 1,860 people who take Norflex or have Gait abnormalities. No report of Gait abnormalities is found in people who take Norflex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Norflex?
Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,832 Norflex users for its effectiveness, alternative drugs and more.
What is Gait Abnormalities?
Gait abnormalities is found to be associated with 1 condition by eHealthMe.
Do you take Norflex and have Gait abnormalities?Check whether Gait abnormalities is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Gait abnormalities and when was it recovered:
Expand to all the drugs that have ingredients of orphenadrine citrate:
Alternative drugs to, pros and cons of Norflex:
- Norflex (1,832 reports)
Gait abnormalities treatments and more:
- Gait abnormalities (28 reports)
COVID vaccines that are related to Gait abnormalities:
- Gait abnormalities in Moderna COVID Vaccine
- Gait abnormalities in Pfizer BioNTech Covid Vaccine
- Gait abnormalities in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Gait abnormalities:
All the conditions that are associated with Gait abnormalities:
How the study uses the data?
The study uses data from the FDA. It is based on orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cefotaxime and Fragmin drug interaction - 2 seconds ago
- Imuran and Procedural Pain - 10 seconds ago
- Bydureon and Anorectal Abscess - 11 seconds ago
- Reopro and Embolism - 14 seconds ago
- Celestone and Ocular Icterus - 14 seconds ago
- Crestor and Glossodynia - 14 seconds ago
- Pepcid Ac and Nosebleed - 19 seconds ago
- Heparin and Chest Wall Abscess - 22 seconds ago
- Ursodiol and Blood Immunoglobulin A Abnormal - 25 seconds ago
- Chronic Kidney Disease and Oesophagitis Haemorrhagic - 26 seconds ago